Does USTEKINUMAB Cause Hepatitis? 347 Reports in FDA Database

Q: Does USTEKINUMAB cause Hepatitis?

347 reports of Hepatitis have been filed with the FDA for USTEKINUMAB, representing 0.4% of all USTEKINUMAB adverse event reports.

Q: How dangerous is Hepatitis from USTEKINUMAB?

Of 347 reports, 229 (66.0%) resulted in death and 299 required hospitalization.

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 347 reports of Hepatitis have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.4% of all adverse event reports for USTEKINUMAB.

347

Reports of Hepatitis with USTEKINUMAB

0.4%

of all USTEKINUMAB reports

229

Deaths

299

Hospitalizations

How Dangerous Is Hepatitis From USTEKINUMAB?

Of the 347 reports, 229 (66.0%) resulted in death, 299 (86.2%) required hospitalization, and 228 (65.7%) were considered life-threatening.

Is Hepatitis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 347 reports have been filed with the FAERS database.

What Other Side Effects Does USTEKINUMAB Cause?

Drug ineffective (12,471) Off label use (10,990) Product dose omission issue (9,405) Fatigue (5,457) Product use issue (5,008) Psoriasis (4,955) Pain (4,872) Rash (4,736) Crohn's disease (4,662) Arthralgia (4,608)

What Other Drugs Cause Hepatitis?

METHOTREXATE (1,835) ACETAMINOPHEN (1,450) TOCILIZUMAB (1,184) HYDROXYCHLOROQUINE (1,133) ADALIMUMAB (1,096) RITUXIMAB (1,017) ETANERCEPT (1,013) LEFLUNOMIDE (997) PEMBROLIZUMAB (935) NIVOLUMAB (930)

Which USTEKINUMAB Alternatives Have Lower Hepatitis Risk?

USTEKINUMAB vs USTEKINUMAB-STBA USTEKINUMAB vs VADADUSTAT USTEKINUMAB vs VALACYCLOVIR USTEKINUMAB vs VALBENAZINE USTEKINUMAB vs VALBENAZINE DITOSYLATE

USTEKINUMAB Full Profile All Hepatitis Reports All Drugs Causing Hepatitis USTEKINUMAB Demographics